• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服环丙沙星、氧氟沙星和洛美沙星可作为静脉抗菌治疗的替代方案。

Oral ciprofloxacin, ofloxacin, and lomefloxacin as alternatives to intravenous antimicrobial therapy.

作者信息

Belliveau P, Nightingale C H, Quintiliani R, Crowe H, Gousee G

机构信息

Hartford Hospital.

出版信息

Conn Med. 1993 Aug;57(8):539-45.

PMID:8243083
Abstract

Ciprofloxacin, ofloxacin, and lomefloxacin are oral fluoroquinolones with ideal characteristics for oral antimicrobial therapy. These agents provide 1) appropriate and reliable serum concentrations, 2) broad antimicrobial activity, 3) proven efficacy in the treatment of serious infections, and 4) good tolerability. Although cations decrease the absorption of these drugs, there are proven means of avoiding these interactions. Therefore, these agents could easily be utilized as alternatives to prolonged intravenous treatment of many infectious diseases in patients who do not have conditions which impair drug absorption.

摘要

环丙沙星、氧氟沙星和洛美沙星是口服氟喹诺酮类药物,具有口服抗菌治疗的理想特性。这些药物具有以下特点:1)血清浓度适宜且可靠;2)抗菌活性广泛;3)在治疗严重感染方面已证实有效;4)耐受性良好。尽管阳离子会降低这些药物的吸收,但已有避免这些相互作用的可靠方法。因此,对于没有影响药物吸收情况的患者,这些药物可轻松用作许多传染病长期静脉治疗的替代药物。

相似文献

1
Oral ciprofloxacin, ofloxacin, and lomefloxacin as alternatives to intravenous antimicrobial therapy.口服环丙沙星、氧氟沙星和洛美沙星可作为静脉抗菌治疗的替代方案。
Conn Med. 1993 Aug;57(8):539-45.
2
Overview of the fluoroquinolone antibiotics.氟喹诺酮类抗生素概述。
Pharmacotherapy. 1993 Mar-Apr;13(2 Pt 2):4S-17S.
3
[Fluoroquinolones--a new and important group of antimicrobial agents].[氟喹诺酮类——一类新型重要抗菌药物]
Tidsskr Nor Laegeforen. 1992 Jan 30;112(3):346-9.
4
Quinolone therapy in intensive care unit settings.
New Horiz. 1993 May;1(2):187-93.
5
In vitro activity of E-4868, a new fluoroquinolone with a 7-azetidin ring, compared with ciprofloxacin, ofloxacin and fleroxacin.新型含7-氮杂环丁烷环氟喹诺酮E-4868与环丙沙星、氧氟沙星和氟罗沙星的体外活性比较
Drugs Exp Clin Res. 1995;21(4):129-38.
6
A multicenter study on the comparative in vitro activity of fleroxacin and three other quinolones: an interim report from 27 centers.氟罗沙星与其他三种喹诺酮类药物体外活性比较的多中心研究:来自27个中心的中期报告
Am J Med. 1993 Mar 22;94(3A):2S-8S.
7
Concentrations in plasma, urinary excretion and bactericidal activity of levofloxacin (500 mg) versus ciprofloxacin (500 mg) in healthy volunteers receiving a single oral dose.单次口服剂量的左氧氟沙星(500毫克)与环丙沙星(500毫克)在健康志愿者体内的血浆浓度、尿排泄及杀菌活性比较
Int J Antimicrob Agents. 2006 Dec;28(6):551-9. doi: 10.1016/j.ijantimicag.2006.07.026. Epub 2006 Nov 13.
8
The fluoroquinolones for urinary tract infections: a review.用于尿路感染的氟喹诺酮类药物:综述
Adv Ther. 1994 Nov-Dec;11(6):277-96.
9
Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society.环丙沙星:一种用于治疗革兰氏阴性病原体感染的口服喹诺酮类药物。抗菌药物委员会。加拿大传染病协会。
CMAJ. 1994 Mar 1;150(5):669-76.
10
Criteria for use of ofloxacin and lomefloxacin in adult inpatients and outpatients.
Clin Pharm. 1993 Jun;12(6):452-8.